Gastric perforation secondary to regression of lung adenocarcinoma after gefitinib treatment

研究成果: Article › 同行評審

原文	English
頁（從 - 到）	e6-e8
期刊	Journal of Clinical Oncology
卷	31
發行號	1
DOIs	https://doi.org/10.1200/JCO.2012.43.5578
出版狀態	Published - 2013 1月 1

All Science Journal Classification (ASJC) codes

@article{39dc7dee83d14642adfacb47357716d9,

title = "Gastric perforation secondary to regression of lung adenocarcinoma after gefitinib treatment",

author = "Chung, \{Wei Pang\} and Song, \{Hsiang Lin\} and Ho, \{Chung Liang\} and Chiu, \{Nan Tsing\} and Su, \{Wu Chou\}",

year = "2013",

month = jan,

day = "1",

doi = "10.1200/JCO.2012.43.5578",

language = "English",

volume = "31",

pages = "e6--e8",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Gastric perforation secondary to regression of lung adenocarcinoma after gefitinib treatment

AU - Chung, Wei Pang

AU - Song, Hsiang Lin

AU - Ho, Chung Liang

AU - Chiu, Nan Tsing

AU - Su, Wu Chou

PY - 2013/1/1

Y1 - 2013/1/1

UR - https://www.scopus.com/pages/publications/84871765740

UR - https://www.scopus.com/pages/publications/84871765740#tab=citedBy

U2 - 10.1200/JCO.2012.43.5578

DO - 10.1200/JCO.2012.43.5578

M3 - Article

C2 - 23169516

AN - SCOPUS:84871765740

SN - 0732-183X

VL - 31

SP - e6-e8

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 1

ER -